KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Return on Equity (2016 - 2025)

Historic Return on Equity for Medtronic (MDT) over the last 11 years, with Q4 2025 value amounting to 0.1%.

  • Medtronic's Return on Equity rose 100.0% to 0.1% in Q4 2025 from the same period last year, while for Oct 2025 it was 0.1%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.1% for FY2025, which is 200.0% up from last year.
  • Per Medtronic's latest filing, its Return on Equity stood at 0.1% for Q4 2025, which was up 100.0% from 0.1% recorded in Q3 2025.
  • Medtronic's Return on Equity's 5-year high stood at 0.1% during Q3 2022, with a 5-year trough of 0.06% in Q1 2021.
  • For the 5-year period, Medtronic's Return on Equity averaged around 0.08%, with its median value being 0.08% (2022).
  • Per our database at Business Quant, Medtronic's Return on Equity crashed by -500bps in 2021 and then surged by 400bps in 2022.
  • Quarter analysis of 5 years shows Medtronic's Return on Equity stood at 0.09% in 2021, then decreased by -9bps to 0.08% in 2022, then decreased by -3bps to 0.08% in 2023, then grew by 11bps to 0.09% in 2024, then increased by 11bps to 0.1% in 2025.
  • Its Return on Equity was 0.1% in Q4 2025, compared to 0.1% in Q3 2025 and 0.1% in Q2 2025.